Gene Expression

Could a one-time CRISPR infusion change how we treat high cholesterol and triglycerides? 🧬 First-in-human Phase 1 data for CTX310 show nearly 50% LDL and ~55% triglyceride reductions after a single IV dose targeting ANGPTL3, with effects seen within two weeks and sustained to at least 60 days and no serious adverse events in this early cohort—signaling potential for durable, one-time cardiovascular risk reduction. The trial also highlights major HEOR and market-access implications if durability and broader safety are confirmed. Read the full article to see the trial details, safety profile, and what this could mean for future lipid-care strategies. #SyenzaNews #biotechnology #clinicaltrials #MarketAccess #costeffectiveness

✨ How can a new model make gene therapies more accessible for vulnerable populations? The groundbreaking gene therapy access model emerges as an innovative solution, fostering collaboration between federal and state entities to negotiate equitable access to high-cost treatments, particularly for Medicaid beneficiaries. This approach not only standardizes costs but also ties payments to patient outcomes, paving the way for a more efficient and inclusive healthcare landscape. Dive into our comprehensive analysis to discover how this model is reshaping healthcare policy and what it means for the future of transformative therapies. #SyenzaNews #HealthEconomics #HealthcareInnovation

🌟 Bupa is making waves in healthcare with its "My Genomic Health" pilot! 🌟 By offering whole genome sequencing to select customers, they're setting a new benchmark in personalized healthcare. This initiative focuses on identifying and managing genetic health risks, empowering customers with tailored health plans and preventative strategies. Check the full article to learn how Bupa is transforming the future of healthcare! #SyenzaNews #PersonalizedHealthcare #Innovation

🔬 Discover the new value framework for NGS in Europe, focusing on key criteria and stakeholder consensus. This framework will guide the effective implementation of NGS, ensuring it meets the needs of the healthcare community. #SyenzaNews #PrecisionMedicine #ValueAssessment #NextGenerationSequencing #ValueFramework #EuropeanOncology 📊 Join the conversation on advancing precision medicine in European oncology. Share your insights on improving access to NGS/CGP diagnostics!

Gene therapies offer groundbreaking treatments for rare diseases, but their high costs pose financial challenges. Discover how focusing on value and exploring alternative payment models can ensure patient access to these life-changing therapies. 🧬 💡 #SyenzaNews #GeneTherapy #HealthcareInnovation #Pharma #PatientCare

Abu Dhabi is making remarkable progress in healthcare through strategic partnerships with leading institutions like CHOP and Penn Medicine. These collaborations aim to advance paediatric oncology, gene therapy, and translational research. 🌍💉 #SyenzaNews #HealthcareInnovation #PaediatricOncology #GeneTherapy #TranslationalResearch #AbuDhabiHealthcare Read more about how these partnerships are set to transform healthcare in Abu Dhabi and beyond.

🌟 Discover the economic impact of genome-wide sequencing on healthcare costs for rare diseases. Our latest study reveals intriguing findings from England and Canada. Explore how GWS is reshaping healthcare dynamics. #SyenzaNews #HealthcareInnovation #GenomeSequencing #RareDiseases #HealthcareCosts

🔍 Understanding QALYs in Healthcare Decision-Making 🔍 The recent passage of HR 485 has sparked a debate on the use of Quality-Adjusted Life Years (QALYs) in healthcare. QALYs are crucial for measuring the effectiveness of medical treatments, ensuring fair treatment for all. Learn about their importance and the potential implications of HR 485. #Healthcare #MedicalResearch #QALYs #HealthPolicy #HealthEconomics #MedicalInnovation

Unveiling the policy of #InnovativeHealthTechnology in Abu Dhabi. Discover how #Biobanks are enhancing and changing healthcare. Read the full article here. 📚👩‍⚕️👨‍⚕️ #HealthTech #MedicalResearch #AbuDhabiHealthcare

🔬 Discover the crucial role of #TPMT and #NUDT15 in #ThiopurineTherapy in our latest article. Understand why genetic testing is essential to optimise treatment, reduce risk, and save costs. Read now ➡️ #Pharmacogenetics #CostEffectiveness #PharmaMarketAccess

🔬 Precision Medicine is paving the way for personalised treatments and improved health outcomes. 💡 Discover how a public-private joint venture in Australia is addressing the challenges posed by this new paradigm in our latest article and how precision medicine could reduce cost in cancer clinical trials. #PrecisionMedicine #HealthcareInnovation #Oncology #CostEffectiveness👉

🔬 Discover research from the UK on the cost-effectiveness of #CeliacDisease screening. We delve into the diagnostic pathway, the role of genetic testing, and the impact on healthcare. 📊 Find out more here: #HealthcareResearch #CostEffectiveness